Cargando…
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
INTRODUCTION: SARS-CoV-2 seroconversion is important for epidemiological studies as well as contact tracing. MATERIAL AND METHODS: The antibody response against SARS-CoV-2 was examined in 111 patients with a positive qRT-PCR. Seroconversion was assessed using the Elecsys from Roche, the Liaison S1/S...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354376/ https://www.ncbi.nlm.nih.gov/pubmed/32829098 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115140 |
_version_ | 1783558072204001280 |
---|---|
author | Wolff, Fleur Dahma, Hafid Duterme, Cécile Van den Wijngaert, Sigi Vandenberg, Olivier Cotton, Frédéric Montesinos, Isabel |
author_facet | Wolff, Fleur Dahma, Hafid Duterme, Cécile Van den Wijngaert, Sigi Vandenberg, Olivier Cotton, Frédéric Montesinos, Isabel |
author_sort | Wolff, Fleur |
collection | PubMed |
description | INTRODUCTION: SARS-CoV-2 seroconversion is important for epidemiological studies as well as contact tracing. MATERIAL AND METHODS: The antibody response against SARS-CoV-2 was examined in 111 patients with a positive qRT-PCR. Seroconversion was assessed using the Elecsys from Roche, the Liaison S1/S2 IgG from Diasorin, the IgG and IgA from Euroimmun, as well as the VIDAS IgG and IgM. Specificity was estimated based on the measurement of SARS-CoV-2 antibodies in 96 residual samples collected during a non-pandemic period. RESULTS: The highest overall sensitivity for detecting seroconversion was obtained using the Elecsys (81.1%), the Euroimmun with a combined detection of IgG/IgA (86.5%), and the VIDAS with a simultaneous measurement of IgG/IgM (78.4%).The Elecsys and the VIDAS IgG/IgM demonstrated a specificity as well as a positive predictive value of 100%. CONCLUSIONS: The Elecsys and the VIDAS methods with a combination of IgG/IgM measurement demonstrated a high sensitivity with no false positive results. |
format | Online Article Text |
id | pubmed-7354376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73543762020-07-13 Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays Wolff, Fleur Dahma, Hafid Duterme, Cécile Van den Wijngaert, Sigi Vandenberg, Olivier Cotton, Frédéric Montesinos, Isabel Diagn Microbiol Infect Dis Virology INTRODUCTION: SARS-CoV-2 seroconversion is important for epidemiological studies as well as contact tracing. MATERIAL AND METHODS: The antibody response against SARS-CoV-2 was examined in 111 patients with a positive qRT-PCR. Seroconversion was assessed using the Elecsys from Roche, the Liaison S1/S2 IgG from Diasorin, the IgG and IgA from Euroimmun, as well as the VIDAS IgG and IgM. Specificity was estimated based on the measurement of SARS-CoV-2 antibodies in 96 residual samples collected during a non-pandemic period. RESULTS: The highest overall sensitivity for detecting seroconversion was obtained using the Elecsys (81.1%), the Euroimmun with a combined detection of IgG/IgA (86.5%), and the VIDAS with a simultaneous measurement of IgG/IgM (78.4%).The Elecsys and the VIDAS IgG/IgM demonstrated a specificity as well as a positive predictive value of 100%. CONCLUSIONS: The Elecsys and the VIDAS methods with a combination of IgG/IgM measurement demonstrated a high sensitivity with no false positive results. Elsevier Inc. 2020-11 2020-07-12 /pmc/articles/PMC7354376/ /pubmed/32829098 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115140 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Virology Wolff, Fleur Dahma, Hafid Duterme, Cécile Van den Wijngaert, Sigi Vandenberg, Olivier Cotton, Frédéric Montesinos, Isabel Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays |
title | Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays |
title_full | Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays |
title_fullStr | Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays |
title_full_unstemmed | Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays |
title_short | Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays |
title_sort | monitoring antibody response following sars-cov-2 infection: diagnostic efficiency of 4 automated immunoassays |
topic | Virology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354376/ https://www.ncbi.nlm.nih.gov/pubmed/32829098 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115140 |
work_keys_str_mv | AT wolfffleur monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays AT dahmahafid monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays AT dutermececile monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays AT vandenwijngaertsigi monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays AT vandenbergolivier monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays AT cottonfrederic monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays AT montesinosisabel monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays |